Sakar Healthcare's Q3 FY 2025-26 Quarterly Results
- 06 Feb 2026
Result Summary
- Sakar Healthcare Ltd reported a 20.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 62.1%.
- Its expenses for the quarter were up by 12.1% QoQ and 56.8% YoY.
- The net profit increased 125.8% QoQ and increased 126.3% YoY.
- The earnings per share (EPS) of Sakar Healthcare Ltd stood at 4.59 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 70.85 | 58.78 | 43.71 | 20.5% | 62.1% |
Total Expenses | 59.90 | 53.42 | 38.19 | 12.1% | 56.8% |
Profit Before Tax | 10.95 | 5.36 | 5.48 | 104.3% | 99.8% |
Tax | 0.70 | 0.82 | 0.94 | -14.6% | -25.5% |
Profit After Tax | 10.25 | 4.54 | 4.53 | 125.8% | 126.3% |
Earnings Per Share | 4.59 | 2.03 | 2.08 | 126.1% | 120.7% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Sakar Healthcare Ltd is a company operating within the pharmaceuticals industry. The company is primarily engaged in the manufacturing and marketing of pharmaceutical formulations. Its product range includes tablets, capsules, liquid orals, dry powders, and ointments. Sakar Healthcare serves various therapeutic areas, meeting diverse healthcare needs. Any significant recent developments specific to Sakar Healthcare Ltd are not available in the provided data, and thus, cannot be commented upon.
Revenue
In the third quarter of the fiscal year 2026 (Q3FY26), Sakar Healthcare Ltd reported a total income of ₹70.85 crores. This represents a quarter-over-quarter (QoQ) increase of 20.5% from the previous quarter (Q2FY26), where the total income was ₹58.78 crores. Year-over-year (YoY), the total income increased by 62.1%, compared to ₹43.71 crores in the third quarter of the previous fiscal year (Q3FY25). This substantial growth in revenue signifies the company's improved sales performance over both the prior quarter and the same quarter of the previous year.
Profitability
For Q3FY26, Sakar Healthcare Ltd recorded a profit before tax of ₹10.95 crores, which shows a significant QoQ increase of 104.3% from ₹5.36 crores in Q2FY26. On a YoY basis, profit before tax nearly doubled, rising by 99.8% from ₹5.48 crores in Q3FY25. After accounting for taxes, the profit after tax was ₹10.25 crores in Q3FY26, up by 125.8% QoQ from ₹4.54 crores in Q2FY26, and by 126.3% YoY from ₹4.53 crores in Q3FY25. Earnings per share (EPS) also saw a notable rise, standing at ₹4.59 in Q3FY26, increasing from ₹2.03 in Q2FY26 and ₹2.08 in Q3FY25, reflecting a 126.1% QoQ and 120.7% YoY growth.
Operating Metrics
Sakar Healthcare Ltd's total expenses for Q3FY26 were ₹59.90 crores, marking a 12.1% increase from Q2FY26, where expenses were ₹53.42 crores. Compared to Q3FY25, the total expenses increased by 56.8% from ₹38.19 crores. The tax expenditure in Q3FY26 was ₹0.70 crores, which saw a reduction of 14.6% QoQ from ₹0.82 crores in Q2FY26 and a 25.5% decrease YoY from ₹0.94 crores in Q3FY25. These metrics suggest an efficient management of tax expenditures despite the increase in total expenses, contributing to the overall profitability of the company.